SCHEMBL29348987

SCHEMBL29348987

O=C1CCC(c2cccc(-c3ccc(N4CCN(CC(F)F)CC4=O)cc3)c2Cl)C(O)N1

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.34
WNT1 P04628 1/20 0.32
DYRK1A Q13627 1/20 0.32
FNTA P49354 2/20 0.31
PGGT1B P53609 2/20 0.31
DRD4 P21917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348653 0.83 CRBN (0.36) P2RX7FNTAPGGT1B
SCHEMBL31068216 0.83 CRBN (0.36) P2RX7FNTAPGGT1B
SCHEMBL29348526 0.77 ROCK2 (0.35)
SCHEMBL29349028 0.75 CNR2 (0.36) P2RX7DRD4
SCHEMBL29348200 0.74 F10 (0.36)
SCHEMBL29348769 0.74 F10 (0.36)
SCHEMBL29348449 0.72 CREBBP (0.46)
SCHEMBL29348776 0.72 CNR2 (0.32)
SCHEMBL31068143 0.71 CRBN (0.35) P2RX7FNTAPGGT1B
SCHEMBL29348519 0.71 HCRTR2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed